Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1923.3% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1383.4 | n/a |
Pr/Book | 0.8 |
Latest | F'cast | |
---|---|---|
Revenue | 109.8% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 3.28 | 0.35 | 0.38p | 235.5 | 0.4 | +660% | 2.50p | 2.8% |
30-Jun-21 | 0.29 | (2.90) | (3.34)p | n/a | n/a | n/a | 5.00p | 4.6% |
30-Jun-22 | 0.02 | (1.64) | (1.95)p | n/a | n/a | n/a | 20.00p | 17.3% |
30-Jun-23 | 0.03 | (2.08) | (2.51)p | n/a | n/a | n/a | 35.00p | 56.0% |
30-Jun-24 | 0.07 | (1.36) | (1.71)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Holding(s) in Company | 07-Jul-2025 | 16:50 | RNS |
Morphic Medical Inc obtains regulatory approval | 03-Jul-2025 | 07:00 | RNS |
Transaction in Own Shares and Total Voting Rights | 02-Jul-2025 | 18:13 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 150.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 155.16 |
52 Week Low | 89.00 |
Volume | 1,003,988 |
Shares Issued | 65.09m |
Market Cap | £97.64m |
Beta | 0.00 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Latest | Previous | |
---|---|---|
2nd Interim | Interim | |
Ex-Div | 15-Jun-23 | 24-Nov-22 |
Paid | 07-Jul-23 | 23-Dec-22 |
Amount | 25.00p | 10.00p |
Time | Volume / Share Price |
13:18 | 200,000 @ 153.50p |
08:00 | 346,336 @ 151.44p |
09:37 | 100,000 @ 153.50p |
09:15 | 100,000 @ 153.50p |
08:50 | 150,000 @ 153.50p |
You are here: research